Physician Specialty Influences Important Aspects of Pediatric Asthma Management

Journal of Allergy and Clinical Immunology: In Practice

Volumn 2, Issue 3, 2014, Pages 306-312.e5

  Aung, Yin Nwe ^a   Majaesic, Carina ^a   Senthilselvan, Ambikaipakan ^a   Mandhane, Piushkumar J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Asthma; Inhaled corticosteroids; Pediatrics; Physician training; Spirometry

Indexed keywords

CORTICOSTEROID; STEROID; ANTIASTHMATIC AGENT;

ALLERGIC RHINITIS; ALLERGY TEST; ARTICLE; ASTHMA; CHILD; COHORT ANALYSIS; COMORBIDITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; OUTCOME ASSESSMENT; PATIENT CARE; PEDIATRIC ALLERGIST; PEDIATRIC RESPIROLOGIST; PEDIATRICIAN; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PREDICTOR VARIABLE; PRESCRIPTION; RETROSPECTIVE STUDY; TREATMENT PLANNING; CLINICAL PRACTICE; DRUG EFFECTS; DRUG UTILIZATION; IMMUNOLOGY; INHALATIONAL DRUG ADMINISTRATION; MEDICINE; PEDIATRICS; PHYSIOLOGY; PROCEDURES; SKIN TEST; STATISTICS AND NUMERICAL DATA; UTILIZATION;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ALLERGY AND IMMUNOLOGY; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; COHORT STUDIES; DRUG UTILIZATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MEDICINE; PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; SKIN TESTS;

EID: 84899919954     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2013.12.005     Document Type: Article

References (27)

1. Cope S.F., Ungar W.J., Glazier R.H. International differences in asthma guidelines for children. Int Arch Allergy Immunol 2009, 148:265-278.
2. Cloutier M.M., Wakefield D.B., Sangeloty-Higgins P., Delaronde S., Hall C.B. Asthma guideline use by pediatricians in private practices and asthma morbidity. Pediatrics 2006, 118:1880-1887.
3. Chen H., Johnson C.A., Haselkorn T., Lee J.H., Israel E. Subspecialty differences in asthma characteristics and management. Mayo Clin Proc 2008, 83:786-793.
4. Diette G.B., Skinner E.A., Nguyen T.T., Markson L., Clark B.D., Wu A.W. Comparison of quality of care by specialist and generalist physicians as usual source of asthma care for children. Pediatrics 2001, 108:432-437.
5. Wu A.C., Gregory M., Kymes S., Lambert D., Edler J., Stwalley D., et al. Modeling asthma exacerbations through lung function in children. J Allergy Clin Immunol 2012, 130:1065-1070.
6. Jia C.E., Zhang H.P., Lv Y., Liang R., Jiang Y.Q., Powell H., et al. The asthma control test and asthma control questionnaire for assessing asthma control: systematic review and meta-analysis. J Allergy Clin Immunol 2013, 131:695-703.
7. Becker A., Swern A., Tozzi C.A., Yu Q., Reiss T., Knorr B. Montelukast in asthmatic patients 6 years-14 years old with an FEV1 > 75%. Curr Med Res Opin 2004, 20:1651-1659.
8. Chauhan B.F., Ducharme F.M. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. Cochrane Database Syst Rev 2012, (5):002314.
9. Arnold D.H., Gebretsadik T., Hartert T.V. Spirometry and PRAM severity score changes during pediatric acute asthma exacerbation treatment in a pediatric emergency department. J Asthma 2013, 50:204-208.
10. Lougheed M.D., Lemiere C., Dell S.D., Ducharme F.M., Fitzgerald J.M., Leigh R., et al. Canadian thoracic society asthma management continuum-2010 consensus summary for children six years of age and over, and adults. Can Respir J 2010, 17:15-24.
11. Kanter L.J., Siegel C.J., Snyder C.F., Pelletier E.M., Buchner D.A., Goss T.F. Impact of respiratory symptoms on health-related quality of life and medical resource utilization of patients treated by allergy specialists and primary care providers. Ann Allergy Asthma Immunol 2002, 89:139-147.
12. Guilbert T.W., Morgan W.J., Zeiger R.S., Mauger D.T., Boehmer S.J., Szefler S.J., et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006, 354:1985-1997.
13. Busse W.W., Pedersen S., Pauwels R.A., Tan W.C., Chen Y.Z., Lamm C.J., et al. The inhaled steroid treatment as regular therapy in early asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma. J Allergy Clin Immunol 2008, 121:1167-1174.
14. Murphy A.C., Proeschal A., Brightling C.E., Wardlaw A.J., Pavord I., Bradding P., et al. The relationship between clinical outcomes and medication adherence in difficult-to-control asthma. Thorax 2012, 67:751-753.
15. Schatz M., Cook E.F., Nakahiro R., Petitti D. Inhaled corticosteroids and allergy specialty care reduce emergency hospital use for asthma. J Allergy Clin Immunol 2003, 111:503-508.
16. Holt E.W., Tan J., Hosgood H.D. The impact of spirometry on pediatric asthma diagnosis and treatment. J Asthma 2006, 43:489-493.
17. Oei S.M., Thien F.C., Schattner R.L., Sulaiman N.D., Birch K., Simpson P., et al. Effect of spirometry and medical review on asthma control in patients in general practice: a randomized controlled trial. Respirology 2011, 16:803-810.
18. Reddel H.K., Taylor D.R., Bateman E.D., Boulet L.P., Boushey H.A., Busse W.W., et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009, 180:59-99.
19. TM. J Allergy Clin Immunol Pract 2013, 1:280-288.
20. Lemanske R.F., Mauger D.T., Sorkness C.A., Jackson D.J., Boehmer S.J., Martinez F.D., et al. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med 2010, 362:975-985.
21. Ducharme F.M., Lasserson T.J., Cates C.J. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Cochrane Database Syst Rev 2006, (4):003137.
22. Lougheed M.D., Lemiere C., Ducharme F.M., Licskai C., Dell S.D., Rowe B.H., et al. Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults. Can Respir J 2012, 19:127-164.
23. Melvin T.A., Patel A.A. Pharmacotherapy for allergic rhinitis. Otolaryngol Clin North Am 2011, 44:727-739.
24. Yamamoto H., Yamada T., Sakashita M., Kubo S., Susuki D., Tokunaga T., et al. Efficacy of prophylactic treatment with montelukast and montelukast plus add-on loratadine for seasonal allergic rhinitis. Allergy Asthma Proc 2012, 33:e17-e22.
25. Philip G., Malmstrom K., Hampel F.C., Weinstein S.F., LaForce C.F., Ratner P.H., et al. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring. Clin Exp Allergy 2002, 32:1020-1028.
26. van Adelsberg J., Philip G., Pedinoff A.J., Meltzer E.O., Ratner P.H., Menten J., et al. Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period. Allergy 2003, 58:1268-1276.
27. Chervinsky P., Philip G., Malice M.P., Bardelas J., Nayak A., Marchal J.L., et al. Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies. Ann Allergy Asthma Immunol 2004, 92:367-373.